Dr. Gavrin joins NeuExcell with over 20 years of industry experience, holding a variety of leadership roles at several major pharma and biotech companies, including Wyeth, Pfizer, and GSK. Most recently, Lori served as VP of Corporate Development at Tmunity Therapeutics where she helped develop and execute the business development strategy, successfully managed complex strategic partnerships, and became an integral part of the Philadelphia cell and gene therapy community.

Dr. Gavrin graduated Summa Cum Laude with a B.A. in chemistry from the Colgate University and obtained her Ph.D. in organic chemistry from the University of Pennsylvania. In addition to her business development acumen, Lori is a recognized leader in the medicinal chemistry community, having worked in the field for a dozen years. Lori previously chaired the Medicinal Chemistry Gordon Research Conference and has 18 patents to her name.

Lori serves on the Executive Committee of the Medicinal Chemistry Section of the American Chemical Society, the Scientific Advisory Board of the Chemistry Department at the University of Pennsylvania, the Oversight Committee of the Coulter Translational Drug Discovery Program at Drexel University and the Board of Directors of the Philadelphia-Israel Chamber of Commerce.